Tag: PerkinElmer

PerkinElmer to acquire antibodies and reagents manufacturer BioLegend

pallavi123- July 26, 2021

PerkinElmer has signed a cash and stock deal worth around $5.25 billion to acquire BioLegend, a California-based antibodies and reagents manufacturer. BioLegend caters to academic ... Read More

PerkinElmer to acquire TB test kit maker Oxford Immunotec for $591m

pharmanewsdaily- January 16, 2021

US medical diagnostic firm PerkinElmer has agreed to acquire Oxford Immunotec Global, a UK-based diagnostics company, for $22 per share or around $591 million. Oxford ... Read More

PerkinElmer to acquire cell engineering company Horizon Discovery

pharmanewsdaily- November 3, 2020

US-based PerkinElmer will acquire UK-based cell engineering company Horizon Discovery Group for nearly $383 million in an all-cash deal. The transaction, which is subject to ... Read More